U.S. Senator Bill Cassidy, Chairman of the Senate Health, Education, Labor, and Pensions Committee, demanded answers from Nara Organics on July 16 after reports linked its infant formula to cases of infant botulism in three states. The Food and Drug Administration recommended that Nara Organics conduct a voluntary recall following three suspected or confirmed cases among infants who consumed the company’s Whole Milk Organic Powdered Infant Formula.
“Ensuring that parents and their infants have access to safe formula is essential for us to protect our most vulnerable population,” Cassidy wrote. “There should never be any question about the quality of these products. The ongoing safety recall affecting Nara Organics’ products undermines access to safe, quality infant formula by putting pressure on the overall supply chain.”
Cassidy previously raised concerns regarding ByHeart’s infant formula after it was associated with 51 cases of infant botulism across 19 states. In his letter to Ms. Hallam at Nara Organics, Cassidy requested detailed responses by July 29 regarding when the company became aware of safety concerns, how it is working with retailers and regulators during the recall process, what testing frameworks are in place for product safety, and whether third-party reviews or proactive facility inspections are conducted.
He also asked if any hazards had been identified at Nara Organics’ facilities in Stendal, Germany within the past five years and what steps were taken in response. Additional questions focused on whether batches sold domestically or internationally had been voluntarily removed due to safety issues and if there has been engagement with foreign regulators about product safety.
Recent reports indicated that a whole milk supplier used by Nara Organics had also supplied another manufacturer involved in a similar recall related to an outbreak of infant botulism. Cassidy requested information about how ingredients from third parties are vetted for contaminants and whether previous concerns with suppliers had arisen.
The Senate Health, Education, Labor, and Pensions Committee oversees federal laws affecting health agencies such as the Food and Drug Administration and plays a significant role in shaping health policy nationwide, according to the official website.